Vertiv Jumps 4.56% As Technicals Signal Bullish Rebound From Key Support

Vertiv Holdings (VRT) advanced 4.56% in the latest session, closing at $131.12, following a volatile period that saw a sharp sell-off on July 10, 2025. This comprehensive technical analysis examines multiple indicators to assess the stock’s near-term trajectory, emphasizing confluence points and potential divergences.
Candlestick Theory
Recent candlestick patterns reveal a bullish engulfing formation emerging after the July 16 low of $122.51. The July 17 candle closed near its high ($133.52 high, $131.12 close) with a long lower wick, reflecting rejection of prices below $127.40 and establishing this as immediate support. Resistance sits near the July 8 swing high of $131.38, with a decisive close above this level potentially targeting $135. The $122–$125 zone now serves as a critical support band, having anchored the mid-July consolidation.
Moving Average Theory
Vertiv’s current price trades above all key moving averages—50-day (~123), 100-day (~116), and 200-day (~103)—signaling a robust long-term uptrend. The 50-day SMA remains above both the 100-day and 200-day SMAs, reinforcing bullish alignment. This multi-timeframe support suggests underlying strength, though a sustained hold above the 50-day SMA near $123 is needed to maintain momentum. The recent bounce from the 50-day SMA on July 14–16 indicates this level remains a reliable dynamic floor.
MACD & KDJ Indicators
MACD (12,26,9) shows a bullish crossover emerging after the histogram turned positive on July 17, indicating accelerating upward momentum. Meanwhile, the KDJ oscillator (9,3) rebounds from oversold territory—%K climbing from 22 to 65 and %D from 18 to 55—reflecting improving short-term momentum. Confluence exists as both indicators transitioned from oversold to bullish confirmation during the July 17 rally. No divergence is observed, though KDJ’s approach toward overbought territory (>80) warrants monitoring for exhaustion signals.
Bollinger Bands
Bollinger Bands (20-day SMA, 2σ) contracted sharply through mid-July, signaling reduced volatility and a coiled spring. The July 17 breakout pushed prices into the upper band, accompanied by a 32% surge in volume vs. the 10-day average, validating the expansion’s bullish intent. This volatility surge suggests near-term upside continuation, though a reversion toward the midline (~124) may occur if the band stretch becomes excessive. The lower band near $116 provides critical long-term support.
Volume-Price Relationship
Volume dynamics corroborate recent reversals: the July 10 capitulation (-5.96%) recorded the year’s highest volume (24.7M shares), suggesting washout conditions. Subsequent recovery rallies—notably July 11 (+2.14%) and July 17 (+4.56%)—occurred on above-average volume, confirming accumulation. The consistent volume uptick during advances vs. lighter volume on pullbacks points to sustainable demand. A divergence would arise if prices climb on dwindling volume, though no such signal exists currently.
Relative Strength Index (RSI)
The 14-day RSI rebounded sharply from oversold (29.6 on July 16) to neutral (57.2 on July 17), reflecting diminishing selling pressure. While RSI exited oversold territory with authority, it remains below the overbought threshold (70), allowing room for further upside. Traders should note this recovery aligns with volume and candlestick signals, though RSI’s warning nature implies confirmation from other indicators is essential before assuming trend persistence. No bearish divergence is evident.
Fibonacci Retracement
Applying Fibonacci to the July decline (swing high: $131.38 on July 8; swing low: $122.51 on July 16), key retracement levels include $124.60 (23.6%), $126.95 (50%), and $127.99 (61.8%). The July 17 close at $131.12 not only breached the 61.8% retracement but also exceeded the prior swing high, exhibiting exceptional strength. This breakout opens the path toward $135 (psychological resistance), with confluence from the candlestick and volume analysis supporting this projection. The 50% retracement level now aligns with the 50-day SMA, reinforcing $124–$125 as critical support.